Responses
Clinical/translational cancer immunotherapy
Original research
Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study
Compose a Response to This Article
Other responses
No responses have been published for this article.